Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells .1. Purine nucleoside analogues

被引:33
作者
Thust, R
Schacke, M
Wutzler, P
机构
[1] Institute for Antiviral Chemotherapy, Friedrich Schiller Univ. of Jena, D-99089 Erfurt
关键词
virostatics; antiherpes nucleosides; purine analogues; chromosome damage;
D O I
10.1016/0166-3542(96)00961-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antiherpes virostatics acyclovir (ACV), valaciclovir (VACV), penciclovir (PCV), famciclovir (FCV) and ganciclovir (GCV), which belong to the group of purine acyclic nucleoside analogues, were tested for clastogenic and sister chromatid exchange (SCE)-inducing activity in Chinese hamster V79-E cells upon chronic application with and without a recovery period. ACV induced borderline effects in both cytogenetic assays, a dose-dependent reduction of the mitotic index and an increasing cell cycle delay. With VACV and PCV only a decrease of the mitotic index and an increase of cell cycle delay were observed. FCV was negative with respect to the four parameters studied, presumably due to the incapacity of the target cells of metabolizing FCV to PCV. GCV was a very potent genotoxin in both assays. It induced a statistically significant SCE response even in the range of the cytomegalovirus IC50 of < 10 mu M. By variation of the experimental protocol it was shown that SCEs are induced in the second cell cycle following exposure to GCV but not in the first one. It is assumed that the drugs under study are metabolized to their respective triphosphates and then inhibit DNA replication as detected by decreasing mitotic index and increasing cell cycle delay. In the case of GCV it is suggested that GCV-TP is incorporated into the target cell DNA and that chromosomal aberrations and SCEs are secondary lesions due to repair processes at the substituted template.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 20 条
[1]   NEW ANTIHERPES DRUGS IN DEVELOPMENT [J].
CAMERON, JM .
REVIEWS IN MEDICAL VIROLOGY, 1993, 3 (04) :225-236
[2]   A DOUBLE-BLIND, PLACEBO-CONTROLLED CYTOGENETIC STUDY OF ORAL ACYCLOVIR IN PATIENTS WITH RECURRENT GENITAL HERPES [J].
CLIVE, D ;
COREY, L ;
REICHMAN, RC ;
DAVIS, LG ;
HOZIER, JC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :753-757
[3]   PRECLINICAL TOXICOLOGY STUDIES WITH ACYCLOVIR - GENETIC TOXICITY TESTS [J].
CLIVE, D ;
TURNER, NT ;
HOZIER, J ;
BATSON, AG ;
TUCKER, WE .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1983, 3 (06) :587-602
[4]  
DARBY G, 1994, ANTIVIR CHEM CHEMOTH, V5, P3
[5]   MUTAGENIC POTENTIAL OF ANTI-HERPES AGENTS [J].
DECLERCQ, E ;
CASSIMAN, JJ .
LIFE SCIENCES, 1986, 38 (03) :281-289
[6]   ANTIVIRAL ACTIVITY SPECTRUM AND TARGET OF ACTION OF DIFFERENT CLASSES OF NUCLEOSIDE ANALOGS [J].
DECLERCQ, E .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1994, 13 (6-7) :1271-1295
[7]   TRENDS IN THE DEVELOPMENT OF NEW ANTIVIRAL AGENTS FOR THE CHEMOTHERAPY OF INFECTIONS CAUSED BY HERPESVIRUSES AND RETROVIRUSES [J].
DECLERCQ, E .
REVIEWS IN MEDICAL VIROLOGY, 1995, 5 (03) :149-164
[8]   CHROMOSOME-ABERRATIONS INDUCED IN-VITRO - MECHANISMS, DELAYED EXPRESSION, AND INTRIGUING QUESTIONS [J].
GALLOWAY, SM .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1994, 23 :44-53
[9]   REPORT FROM WORKING GROUP ON IN-VITRO TESTS FOR CHROMOSOMAL-ABERRATIONS [J].
GALLOWAY, SM ;
AARDEMA, MJ ;
ISHIDATE, M ;
IVETT, JL ;
KIRKLAND, DJ ;
MORITA, T ;
MOSESSO, P ;
SOFUNI, T .
MUTATION RESEARCH, 1994, 312 (03) :241-261
[10]   COMPARISON OF COMMON GENE MUTATION TESTS IN MAMMALIAN-CELLS IN CULTURE - A POSITION PAPER OF THE GUM-COMMISSION-FOR-THE-DEVELOPMENT-OF-GUIDELINES-FOR-GENOTOXICITY-TESTING [J].
GLATT, H .
MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS, 1994, 313 (01) :7-20